SCHEDULE 13G/A: Sean McClain Amends Absci Corporation Ownership Disclosure, Retaining 8.3% Stake

Sean McClain has filed an amended Schedule 13G, confirming his beneficial ownership of 8.3% of Absci Corporation's common stock as of March 31, 2025.

Summary

• Sean McClain, an individual, has filed an Amendment No. 1 to Schedule 13G, updating his beneficial ownership in Absci Corporation.
• As of March 31, 2025, Mr. McClain beneficially owns an aggregate of 10,760,728 shares of Absci Corporation's common stock.
• This ownership represents 8.3% of the company's common stock, calculated based on 127,353,236 shares outstanding as of March 28, 2025, plus 2,024,772 shares from options exercisable by Mr. McClain.
• Mr. McClain holds sole voting power over all 10,760,728 beneficially owned shares.
• His sole voting power includes 6,456,420 shares held of record by him, 2,269,987 shares held by Brittany McClain subject to a voting agreement, 2,024,772 shares from options exercisable by him within 60 days, and 9,549 shares from options exercisable by Brittany McClain also subject to a voting agreement.
• Mr. McClain holds sole dispositive power over 8,481,192 shares, comprising 6,456,420 shares held of record by him and 2,024,772 shares from options exercisable by him within 60 days.

Sentiment

Score: 5

Explanation: A Schedule 13G filing is a factual disclosure of beneficial ownership and does not inherently convey positive or negative sentiment, unless there's a significant change in stake or a new activist investor. This is an amendment updating existing information, which is a routine regulatory event.

Positives

• Sean McClain, a key individual (likely a founder or executive), maintains a significant beneficial ownership of 8.3% in Absci Corporation, indicating continued alignment with shareholder interests and confidence in the company's future.

Future Outlook

This document is a beneficial ownership disclosure and does not contain forward-looking statements or guidance regarding the company's future outlook.

Industry Context

This Schedule 13G filing is a routine regulatory disclosure of beneficial ownership by a significant individual shareholder in Absci Corporation, a biotechnology company. It does not provide broader insights into industry trends or competitive landscape.

Related Party Transactions

• Shares held by Brittany McClain (2,269,987 common shares and 9,549 option shares) are subject to a voting agreement and proxy, entitling Sean McClain to vote these shares on all matters presented to the Issuer's stockholders for approval.

Stakeholder Impact

• Shareholders: Provides transparency regarding the significant ownership stake and voting control held by Sean McClain, which can influence perceptions of insider alignment and stability.

Key Dates

Keywords

Absci Corporation, Sean McClain, Schedule 13G, beneficial ownership, common stock, SEC filing, ownership stake, biotechnology, biopharma